XML 28 R21.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Schedule Of Expense Segment Reporting In formation | The significant expense categories within net loss are presented on the condensed consolidated statements of operations. The research and development expenses have been disaggregated as follows (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Tarcocimab program expenses |  | $ | 11,886 |  |  | $ | 9,157 |  |  | $ | 26,162 |  |  | $ | 15,126 |
KSI-501 and KSI-101 program expenses |  |  | 5,309 |  |  |  | 1,080 |  |  |  | 9,526 |  |  |  | 3,301 |
ABC Platform and other program expenses |  |  | 6,421 |  |  |  | 3,115 |  |  |  | 12,066 |  |  |  | 5,701 |
Payroll and personnel expenses |  |  | 14,109 |  |  |  | 14,492 |  |  |  | 28,379 |  |  |  | 28,851 |
Facilities and other research and development expenses |  |  | 5,035 |  |  |  | 4,670 |  |  |  | 10,271 |  |  |  | 9,466 |
Total research and development expenses |  | $ | 42,760 |  |  | $ | 32,514 |  |  | $ | 86,404 |  |  | $ | 62,445 |

X
- Definition Schedule Of Expense Segment Reporting Information Table Text Block + References No definition available. + Details
Name: | kod_ScheduleOfExpenseSegmentReportingInformationTableTextBlock
Namespace Prefix: | kod_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration